<DOC>
	<DOCNO>NCT01514812</DOCNO>
	<brief_summary>This study evaluate effect YM150 plasma concentration digoxin healthy subject .</brief_summary>
	<brief_title>A Study Investigate Effect YM150 Plasma Concentration Digoxin Healthy Subjects</brief_title>
	<detailed_description>The study double blind , randomize , two period crossover design . Two treatment , digoxin combination YM150 , digoxin combination placebo , evaluate . Each subject receive treatment random order . Placebo use maintain blind . Males females equally divide treatment order . Subjects dose digoxin either YM150 placebo 8 day reach steady state . In second period subject receive digoxin alternate treatment . There washout period least 10 day consecutive treatment . In study period subject admit day prior study drug administration ( Day 0 ) . The subject discharge Day 10 . Approximately one week last discharge , subject return unit post study visit .</detailed_description>
	<mesh_term>Digoxin</mesh_term>
	<mesh_term>Darexaban</mesh_term>
	<criteria>Healthy , judge investigator subinvestigator base result physical examination test Body weight : male : ≥60 kg , &lt; 100 kg ; female : ≥45.0 kg , &lt; 80.0 kg BMI ( screen ) : ≥18.0 , &lt; 30.0 Female subject childbearing potential , practice adequate method prevent pregnancy , like abstinence double barrier method Known suspect hypersensitivity / allergy FXa inhibitor , digoxin , heart glycoside general constituent formulation use History and/or sign symptom indicate current abnormal hemostasis blood dyscrasia , include limited neutropenia , thrombocytopenia , thrombocytopathy , thromboasthenia , hemophilia , Von Willebrand 's disease , vascular purpura , bleed gum , frequent nose bleed Family history congenital vascular malformation ( e.g . Marfan 's Syndrome ) and/or bleed disorder ( e.g . hemophilia , Von Willebrand 's disease , Christmas disease ) PT aPTT screen visit outside normal range History peptic ulcer organic lesion susceptible bleed Any surgical intervention ( include tooth extraction ) trauma within last 3 month precede initiation study Any clinically significant history upper gastrointestinal symptom ( nausea , vomit , abdominal discomfort upset , heartburn ) 4 week prior admission Research Unit Any clinically significant history disease disorder gastrointestinal , cardiovascular , respiratory , renal , hepatic , neurological , dermatological , psychiatric metabolic Any liver function test ( ALAT , ASAT , LDH γGT ) upper limit normal range ( ULN ) Any clinically significant abnormality follow investigator 's review prestudy physical examination , ECG clinical laboratory test Abnormal pulse rate blood pressure measurement prestudy visit follow : Pulse rate &lt; 40 &gt; 90 bpm ; systolic blood pressure &lt; 95 &gt; 160 mmHg ; diastolic blood pressure &lt; 40 &gt; 95 mmHg ( measurement take subject rest supine position 5 min ) Regular use prescribe OTC ( overthecounter ) drug ( include natural herbal remedy especially Pgp inhibit activity , like St. John 's worth ) four week prior admission Research Unit OR use drug ( include natural herbal remedy ) well vitamins two week prior admission Research Unit Donation blood blood product within 3 month prior admission Research Unit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>YM150</keyword>
	<keyword>digoxin</keyword>
	<keyword>drug-drug interaction</keyword>
	<keyword>Plasma concentration</keyword>
	<keyword>darexaban</keyword>
	<keyword>Pharmacokinetics digoxin</keyword>
</DOC>